What medications are used to treat coronary heart disease?

Jun 01, 2022 Source: Cainiu Health
Dr. Tian Hongbo
Introduction
The primary therapeutic drugs include lipid-lowering agents, with statins being the most commonly used—such as Lipitor (atorvastatin calcium tablets). Antiplatelet agents tailored to the patient’s condition are also required; oral aspirin is the most frequently prescribed. Nitrates exert a coronary artery–dilating effect. Calcium channel blockers may also be employed. Beta-blockers constitute a cornerstone of coronary heart disease treatment.

Coronary artery disease (CAD) is a common cardiac condition; appropriate understanding of this disease often leads to excellent therapeutic outcomes. So, what medications are used to treat CAD?

What medications are used to treat coronary artery disease?

Primary pharmacological treatments include:

  • Lipid-lowering agents: Adults with CAD frequently have concomitant hyperlipidemia and thus require lipid-lowering therapy. Statins are the most commonly prescribed class of lipid-lowering drugs, including Lipitor (atorvastatin calcium tablets). These agents not only lower serum lipid levels but also stabilize coronary artery plaques.
  • Antiplatelet agents: Platelet activation plays a key role in the pathogenesis of CAD; therefore, targeted antiplatelet therapy is essential. Aspirin, administered orally, is the most widely used antiplatelet drug.
  • Nitrates: These agents dilate coronary arteries. During the acute phase of CAD—particularly in cases of unstable angina—or when long-acting nitrate esters are prescribed orally, nitrates help vasodilate coronary vessels and improve myocardial blood supply.

Additional therapeutic options include:

  • Calcium channel blockers: These increase coronary blood flow while reducing myocardial oxygen demand.
  • β-blockers: Considered cornerstone medications in CAD management, β-blockers reduce heart rate, decrease myocardial oxygen consumption, and enhance coronary perfusion.

All CAD medications must be prescribed and closely monitored by a specialist physician, with long-term follow-up of the patient. If pharmacotherapy proves inadequate or if acute myocardial infarction occurs, timely interventional treatment for CAD—such as percutaneous coronary intervention (PCI)—may be required to salvage ischemic myocardium. We hope this information is helpful to you!


Related Articles

View All